- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Insulin Glargine Pen Injector [Lantus]
Total 1095 results
-
prof dr Pieter GillardUniversity Hospital, Antwerp; Onze Lieve Vrouw HospitalCompleted
-
SanofiCompletedType 1 Diabetes MellitusGermany
-
SanofiCompletedDiabetes Mellitus, Type 2
-
Changhua Christian HospitalRecruitingDiabetic Ketoacidosis | Hyperglycaemic Crisis in Diabetes Mellitus | Hyperglycaemic Hyperosmolar Nonketotic SyndromeTaiwan
-
University Hospital TuebingenTerminatedDiabetes Mellitus, Type 2Germany
-
Emory UniversityCompletedHyperglycemiaUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1 | Healthy VolunteersUnited States
-
University of Texas Southwestern Medical CenterNovo Nordisk A/STerminatedType 1 DiabetesUnited States
-
Eli Lilly and CompanyCompletedType 2 Diabetes | Type 2 Diabetes Treated With InsulinUnited States, Germany, Mexico, Argentina, Puerto Rico, Italy, Spain, India
-
Emory UniversityCompleted
-
SanofiCompleted
-
HealthPartners InstituteSanofi; International Diabetes Center at Park NicolletCompletedType 2 DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany, Spain, France, Norway, Romania
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Healthy VolunteersGermany
-
SanofiCompletedDiabetes Mellitus, Type 2France
-
Novo Nordisk A/SCompletedHealthy | Diabetes Mellitus, Type 2 | DiabetesGermany
-
SanofiCompletedType I Diabetes MellitusBrazil
-
Novo Nordisk A/SCompleted
-
Rabin Medical CenterSanofiTerminated
-
Emory UniversityCompletedDiabetes Mellitus | Type 1 DiabetesUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Australia, Russian Federation, Spain, Mexico, Canada, France, Korea, Republic of
-
SanofiCompletedDiabetes Mellitus, Insulin-DependentUnited States
-
SanofiCompleted
-
Mount Sinai Hospital, CanadaCanadian Institutes of Health Research (CIHR)Completed
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesAustria, Hungary, Slovenia, Germany, Czech Republic, Poland, Slovakia
-
Mira ZuidgeestSanofi; Innovative Medicines Initiative; IMI Trials@Home consortiumActive, not recruitingDiabetes Mellitus, Type 2Germany, United Kingdom, Denmark
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina, Mexico, Korea, Republic of, Russian Federation
-
SanofiCompletedType 2 Diabetes MellitusUnited States
-
SanofiActive, not recruiting
-
SanofiCompleted
-
Jian-hua MaCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Taiwan, China, Korea, Republic of
-
SanofiCompleted
-
University of Maryland, BaltimoreCompletedDiabetic KetoacidosisUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Poland, Slovakia, Canada, Slovenia, Greece, Czechia
-
WockhardtCompletedType1 DiabetesUnited States
-
Federico II UniversityCompletedGlucose Metabolism Disorders | Cystic FibrosisItaly
-
Mount Sinai Hospital, CanadaCanadian Institutes of Health Research (CIHR)Completed
-
Chongqing Medical UniversityCompleted
-
Baylor College of MedicineCompletedHyperglycemia | Diabetes MellitusUnited States
-
SanofiCompleted
-
SanofiCompletedDiabetesPeru, Ukraine, Colombia, Egypt, India, Indonesia, Israel, Jordan, Kuwait, Lebanon, Mexico, Philippines, Russian Federation, Saudi Arabia, Singapore, Taiwan, Thailand, United Arab Emirates
-
SanofiCompleted
-
University Hospital TuebingenMedical University of Vienna; University of Bern; CenTrial GmbHTerminatedObesity | DiabetesAustria, Germany, Switzerland
-
Washington University School of MedicineCompletedHyperglycemia | Lymphoma | Diabetes Mellitus, Type 2United States
-
SanofiCompletedType 2 Diabetes MellitusGermany, United Kingdom
-
Population Health Research InstituteMerck Sharp & Dohme LLCCompletedType 2 Diabetes MellitusCanada
-
Medical University of South CarolinaCompletedHyperglycemia | Diabetes | Kidney TransplantationUnited States